A Popular Weight Loss Drug Is Getting a Price Cut
Eli Lilly will now sell cheaper vials of Zepbound, presenting a direct challenge to telehealth companies that offer compounded versions of the medication.
Read More from the Global Wellness News ™
- Calm Debuts Mindful Social Media Replacement
- Longevity Focused Company Completes $39.8 Million Funding Round